Bluejay Diagnostics is pleased to present the Symphony biomarker detection platform. The system aims to help improve healthcare outcomes by detecting and preventing cytokine-driven health scares early on.
Symphony is an innovative implementation of the traditionally reliable ELISA methodology combined with modern advances in nanotechnology. The unique design features a combination of microfluidics and interrupted fluid dynamics to offer a fast, simple, safe, and highly sensitive biomarker detection platform.
Bluejay Diagnostics is leveraging its proprietary technology platform to develop innovative point-of-care tests. It is our mission to use this fast, reliable and cost-effective platform to provide patients and providers access to affordable and timely healthcare. The following chart summarizes the projects in which the company is currently engaged.